World Kidney Day: Managing Hyperkalemia Critical for Chronic Kidney Disease Patients

The second Thursday of March each year marks World Kidney Day. This globally observed day raises awareness about the importance of preventing kidney disease, early diagnosis, and appropriate treatment. This year, it falls on March 12. The Korean Society of Nephrology is leading various educational and promotional events to mark the occasion. Chronic kidney disease (CKD) has become a relatively common condition, affecting approximately 10% of the adult population worldwide. When kidney function declines, various complications including cardiovascular disease develop, significantly reducing quality of life. If the disease progresses to end-stage kidney disease, patients require lifelong dialysis or kidney transplantation. In this regard, kidney disease is a critical public health issue that extends beyond individual health concerns to create socioeconomic burdens for families, communities, and nations. Despite its severity, CKD requires particular vigilance because it typically progresses silently. Many patients experience no symptoms until kidney function has significantly deteriorated, often only recognizing the disease after it has advanced. Therefore, early diagnosis and consistent management of kidney disease are paramount. The kidneys are vital organs that excrete waste products and maintain fluid and electrolyte balance in the body. When kidney function declines, the ability to maintain this homeostasis weakens, causing various problems. Among these, hyperkalemia demands special attention. Hyperkalemia is a common electrolyte abnormality in CKD patients. As kidney function decreases, the ability to excrete potassium diminishes, causing blood potassium levels to rise easily. While potassium is an essential electrolyte for maintaining nerve and muscle function and the heart's electrical stability, excessively high levels can lead to fatal arrhythmias or cardiac arrest. Research indicates that hyperkalemia prevalence among CKD patients is reported at approximately 10-20% or higher. The frequency is even greater in patients with severe kidney function decline or accompanying heart failure. Furthermore, hyperkalemia is known to be associated with increased hospitalizations, cardiovascular events, and even elevated mortality risk beyond simple laboratory abnormalities. Another reason hyperkalemia management is important is its potential impact on CKD treatment strategies themselves. Renin-angiotensin-aldosterone system (RAAS) inhibitors, widely used to improve outcomes in CKD patients, play a crucial role in reducing proteinuria, protecting kidney function, and decreasing cardiovascular events. However, these medications can elevate blood potassium levels, sometimes requiring dose reduction or discontinuation when hyperkalemia develops. The problem is that stopping these important medications can lead to long-term kidney function deterioration or increased cardiovascular risk. Fortunately, new treatment strategies for more effective hyperkalemia management have recently emerged. Notably, new potassium binders such as Sodium Zirconium Cyclosilicate have been introduced in Korea, increasing the possibility of controlling hyperkalemia while continuing existing RAAS inhibitor therapy. This medication works by selectively binding potassium in the intestine and promoting its excretion, thereby lowering blood potassium levels. Clinical studies have reported that it can help with potassium control and treatment continuation in patients with CKD or heart failure. On World Kidney Day, we need to reconsider the importance of hyperkalemia in CKD management. Hyperkalemia is not simply an electrolyte abnormality but a significant clinical issue that can affect patients' treatment strategies and long-term prognosis. Our kidneys work silently 24 hours a day, 365 days a year without rest. However, when their function weakens, our lives can easily be shaken. Protecting these precious organs is a task that cannot be delayed. On the occasion of World Kidney Day, we hope for greater social awareness of the importance of kidney health and the necessity of electrolyte management.

World Kidney Day: Managing Hyperkalemia Critical for Chronic Kidney Disease Patients

Related Video

June Local Elections Struggle with Waste Banner Crisis

Why Health Is a System, Not Just Research

K-Bio's Next Act Hinges on Professional Management

Surviving the 'Age of Conflict'

Shin Hyun-song Should Stand Firm Against Any 'External Pressure' as BOK Governor

Upstage Becomes Korea's First AI Startup Unicorn, Eyes Daum Acquisition and B2C Expansion

March Employment Up 206,000, But Youth Jobs Fall for 41st Straight Month

Samsung SDS Secures 1.2 Trillion Won from KKR to Accelerate AI and M&A Expansion

Seoul Land Transaction Permit Applications Hit 484 Daily as Gangnam 3 Districts Surge Up to 257%

KOSPI Hits 6091, Recovers to Pre-War Levels; 7000 Within Reach This Month